Indian Cipla Limited will produce an affordable version of the product at its plants in Benoni or Durban South Africa is set to become a manufacturing hub for an affordable version of the innovative HIV-prevention drug CAP-LA. The move is expected to provide millions of people with access to the drug in a region that the World Health Organization (WHO) says accounts for almost two-thirds of new HIV infections globally. The drug, cabotegravir long-acting (LA), will be produced by Cipla Limited, an Indian multinational pharmaceutical company, at its plants in Benoni or Durban, The Guardian reported on Thursday. Last
Hence then, the article about south africa to become manufacturing hub for hiv prevention drug was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( South Africa to become manufacturing hub for HIV-prevention drug )